VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
PFS Doubled! Novel Drug Chiauranib Reduces Progression/Death Risk by 57% in Platinum-Resistant Ovarian Cancer
PFS Doubled! Novel Drug Chiauranib Reduces Progression/Death Risk by 57% in Platinum-Resistant Ovarian Cancer
May 30, 2026 20:20 CST Updated May 31, 02:33
Share:
